Showing results (1-10 of 13) with videos related to
Sort By:
Pageof 2
Chemmedchem|February 3, 2016
Cancer Immunotherapy: Selected Targets and Small-Molecule ModulatorsHilmar WeinmannChemmedchem|October 16, 2013
Small-molecule modulators for epigenetics targetsStefan Knapp, Hilmar WeinmannExpert Opinion on Therapeutic Patents|September 30, 2009
Recent patent trends in the field of progesterone receptor agonists and modulatorsNorbert Schmees, Hilmar WeinmannChemmedchem|February 6, 2014
Bromodomains and their pharmacological inhibitorsDaniel Gallenkamp, Kathy A Gelato, Bernard Haendler, et al.Molecules (Basel, Switzerland)|April 3, 2021
Improved Diazo-Transfer Reaction for DNA-Encoded Chemistry and Its Potential Application for Macrocyclic DEL-LibrariesSelahattin Ede, Mandy Schenk, Donald Bierer, et al.The Journal of Organic Chemistry|June 11, 2008
Synthesis of 7a-substituted Hajos-Wiechert ketone analoguesJason W J Kennedy, Sophia Vietrich, Hilmar Weinmann, et al.Angewandte Chemie (International Ed. in English)|March 27, 2025
Chemical Process Development in the Pharmaceutical Industry in Europe-Insights and Perspectives from Industry ScientistsJoachim Krueger, André P Dieskau, Jorma Hassfeld, et al.Journal of Medicinal Chemistry|April 13, 2012
Dabigatran and dabigatran ethyl ester: potent inhibitors of ribosyldihydronicotinamide dehydrogenase (NQO2)Simon Michaelis, Anett Marais, Anna K Schrey, et al.Journal of Medicinal Chemistry|November 1, 2019
Discovery of BAY-298 and BAY-899: Tetrahydro-1,6-naphthyridine-Based, Potent, and Selective Antagonists of the Luteinizing Hormone Receptor Which Reduce Sex Hormone Levels in VivoLars Wortmann, Bernhard Lindenthal, Peter Muhn, et al.Bioconjugate Chemistry|June 6, 2022
A Novel NAMPT Inhibitor-Based Antibody-Drug Conjugate Payload Class for Cancer TherapyNiels Böhnke, Markus Berger, Nils Griebenow, et al.Pageof 2